- €2.00bn
- €2.75bn
- €7.15bn
- 15
- 55
- 15
- 17
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,067 | 2,285 | 2,264 | 3,742 | 7,150 |
Cost of Revenue | |||||
Gross Profit | 445 | 563 | 603 | 295 | 0.485 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,894 | 2,212 | 2,024 | 3,226 | 7,435 |
Operating Profit | 173 | 72.4 | 240 | 516 | -284 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 156 | 54.4 | 220 | 508 | -278 |
Provision for Income Taxes | |||||
Net Income After Taxes | 129 | 48.3 | 180 | 377 | -183 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 129 | 48.2 | 180 | 377 | -185 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 129 | 48.2 | 180 | 377 | -185 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 29.3 | 11.7 | 36.2 | 90.1 | -44 |
Dividends per Share |